Nutritional supplementation with branched-chain amino acids in advanced cirrhosis: A double-blind, randomized trial

Gastroenterology

Volumn 124, Issue 7, 2003, Pages 1792-1801

  Marchesini, Giulio ^a,g   Bianchi, Giampaolo ^a   Merli, Manuela ^b   Amodio, Piero ^c   Panella, Carmine ^d   Loguercio, Carmela ^e   Fanelli, Fillipo Rossi ^b   Abbiati, Roberto ^f  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITY OF PADOVA   (Italy)

^d UNIVERSITY OF FOGGIA   (Italy)

^e UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^f Bracco Imaging SpA   (Italy)

^g UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMINOID; BRANCHED CHAIN AMINO ACID; LACTALBUMIN; MALTODEXTRIN;

ADULT; AGED; ANOREXIA; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; DIET SUPPLEMENTATION; DISEASE MARKER; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; FEMALE; HEALTH STATUS; HOSPITAL ADMISSION; HUMAN; LABORATORY TEST; LENGTH OF STAY; LIVER CIRRHOSIS; LIVER FAILURE; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NUTRITIONAL STATUS; OUTCOMES RESEARCH; PATIENT COMPLIANCE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM;

EID: 0038047688     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0016-5085(03)00323-8     Document Type: Article

References (40)

1. Lautz HU, Selberg O, Körber J, Bürger M, Müller MJ. Forms of malnutrition in patients with liver cirrhosis. Clin Invest 1992;70: 178-186.
2. Crawford DHG, Shepherd RW, Halliday JW, Cooksley GWGE, Golding SD, Cheng WSC, Powell LW. Body composition in nonalcoholic cirrhosis: the effect of disease etiology and severity on nutritional compartments. Gastroenterology 1994;106:1611-1617.
3. Nielsen K, Kondrup J, Martinsen C, Shilling B, Wikman B. Nutritional assessment and adequacy of dietary intake in hospitalized patients with alcoholic cirrhosis. Br J Nutr 1993;69:665-679.
4. Italian Multicentre Cooperative Project on nutrition in liver cirrhosis. Nutritional status in cirrhosis. J Hepatol 1994;21:317-325.
5. Prijamoto D, Strauss BJG, Lambert JR, Sievert W, Stroud DB, Wahlquist ML, Katz B, Colman J, Jones P, Korman MG. Early detection of protein depletion in alcoholic cirrhosis: role of body composition analysis. Gastroenterology 1993;105:1839-1845.
6. Plauth M, Merli M, Kondrup J, Weimann A, Ferenci P, Muller MJ, for the ESPEN Consensus Group. ESPEN guidelines for nutrition in liver disease and transplantation. Clin Nutr 1997;16:43-55.
7. Swart GR, van den Berg JWO, Wattinema DL, Rietvald T, van Vuure JK, Frenkel M. Elevated protein requirements in cirrhosis of the liver investigated by whole body protein turnover studies. Clin Sci 1988;75:101-107.
8. McCullough AJ, Tavill AS. Disordered energy and protein metabolism in liver disease. Semin Liver Dis 1991;11:265-277.
9. Mullen KD, Denne SC, McCullough AJ, Savin SM, Bruno D, Tavill AS, Kalhan SC. Leucine metabolism in stable cirrhosis. Hepatology 1986;6:622-630.
10. Owen OE, Trapp VE, Reichard GA Jr, Mozzoli MA, Moctezuma J, Paul P, Skutches CL, Boden G. Nature and quantity of fuels consumed in patients with alcoholic cirrhosis. J Clin Invest 1983; 72:1821-1832.
11. Diehl AM. Nutrition, hormones, metabolism and liver regeneration. Semin Liver Dis 1991;11:115-120.
12. Laviano A, Cangiano C, Preziosa I, Riggio O, Conversano L, Cascino A, Ariemma S, Rossi-Fanelli F. Plasma tryptophan levels and anorexia in liver cirrhosis. Int J Eat Disord 1997;21:181-186.
13. Tessari P, Zanetti M, Barazzoni R, Biolo G, Orlando R, Vettore M, Inchiostro S, Perini P, Tiengo A. Response of phenylalanine and leucine kinetics to branched chain-enriched amino acids and insulin in patients with cirrhosis. Gastroenterology 1996;111: 127-137.
14. Panella C, Guglielmi F, Laddaga L, Gabrielli L, Giaccari S, Antonaci F, Puca FM, Francavilla A. Oral branched-chain amino acids in the treatment of low-grade portosystemic encephalopathy: a long term multicentre trial, In: Francavilla A, Panella C, DiLeo A, Van Thiel DH, eds. Liver and hormones. New York: Raven, 1987: 97-106.
15. Davidson HI, Richardson R, Sutherland D, Garden OJ. Macronutrient preference, dietary intake, and substrate oxidation among stable cirrhotic patients. Hepatology 1999;29:1380-1386.
16. Rossi-Fanelli F, Cangiano C. Increased availability of tryptophan in brain as common pathogenic mechanism for anorexia associated with different diseases. Nutrition 1991;7:364-367.
17. Fabbri A, Magrini N, Bianchi G, Zoli M, Marchesini G. Overview of randomized clinical trials of oral branched-chain amino acid treatment in chronic hepatic encephalopathy. J Parenter Enteral Nutr 1996;20:159-164.
18. Yoshida T, Muto Y, Moriwaki H, Yamato M. Effect of long-term oral supplementation with branched-chain amino acid granules on the prognosis of liver cirrhosis. Gastroenterol Jpn 1988;24: 692-698.
19. Hirsch S, Bunout D, de la Maza P, Iturriaga H, Petermann M, Icazar G, Gattas V, Ugarte G. Controlled trial on nutrition supplementation in outpatients with symptomatic alcoholic cirrhosis. J Parenter Enteral Nutr 1993;17:119-124.
20. Marchesini G, Bianchi G, Amodio P, Salerno F, Merli M, Panella C, Loguercio C, Apolone G, Niero M, Abbiati R. Factors associated with poor health-related quality of life of patients with cirrhosis. Gastroenterology 2001;120:170-178.
21. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973;60:646-649.
22. Conn HO. Trailmaking and number-connection tests in the assessment of mental state in portal systemic encephalopathy. Am J Dig Dis 1977;22:541-550.
23. Capocaccia L, Fischer JE, Rossi-Fanelli F. Assessment and evaluation of hepatic encephalopathy. In: Capocaccia L, Fischer JE, Rossi-Fanelli F, eds. Hepatic encephalopathy in chronic liver failure. New York: Raven, 1984:239-244.
24. Frisancho AR. New norms of upper limb fat and muscle areas for assessment of nutritional status. Am J Clin Nutr 1981;34:2540-2545.
25. Lolli R, Marchesini G, Bianchi G, Fabbri A, Bugianesi E, Zoli M, Pisi E. Anthropometric assessment of the nutritional status of patients with liver cirrhosis in an Italian population. Ital J Gastroenterol 1992;24:429-435.
26. Raben A, Tagliabue A, Astrup A. The reproducibility of subjective appetite scores. Br J Nutr 1995;73:517-530.
27. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473-483.
28. Marchesini G, Dioguardi FS, Bianchi GP, Zoli M, Bellati G, Roffi L, Martines D, Abbiati R. Long-term oral branched-chain amino acid treatment in chronic hepatic encephalopathy. A randomized double-blind casein-controlled trial. J Hepatol 1990;11:92-101.
29. Plauth M, Egberts EH, Hamster W, Torok M, Muller PH, Brand O. Long-term treatment of latent portosystemic encephalopathy with branched-chain amino acids. A double-blind placebo-controlled cross-over study. J Hepatol 1993;17:308-314.
30. O'Keefe SJ, El-Zayadi AR, Carraher TE, Davis M, Williams R. Malnutrition and immuno-incompetence in patients with liver disease. Lancet 1980;2:615-617.
31. Kalman DR, Saltzman JR. Nutrition status predicts survival in cirrhosis. Nutr Rev 1996;54:217-219.
32. Alberino F, Gatta A, Amodio P, Merkel C, Di Pascoli L, Boffo G, Caregaro L. Nutrition and survival in patients with liver cirrhosis. Nutrition 2001;17:445-450.
33. Swart GR, Zillikens MC, van Vuure JK, van den Berg JW. Effect of a late evening meal on nitrogen balance in patients with cirrhosis of the liver. Br Med J 1989;299:1202-1203.
34. Cangiano C, Laviano A, Meguid MM, Mulieri M, Conversano L, Preziosa I, Rossi-Fanelli F. Effects of administration of oral branched-chain amino acids on anorexia and caloric intake in cancer patients. J Natl Cancer Inst 1996;88:550-552.
35. Marchesini G, Zoli M, Dondi C, Bianchi GP, Cirulli M, Pisi E. Anticatabolic effects of branched-chain amino acid-enriched solutions in patients with liver cirrhosis. Hepatology 1982;2:420-425.
36. Apolone G, De Carli G, Brunetti M, Garattini S. Health-related quality of life (HR-QOL) and regulatory issues. An assessment of the European Agency for the Evaluation of Medicinal Products (EMEA) recommendations on the use of HR-QOL measures in drug approval. Pharmacoeconomics 2001;19:187-195.
37. Conn HO. A peek at the Child-Turcotte classification. Hepatology 1981;1:673-676.
38. Albers I, Hartmann H, Bircher J, Creutzfeldt W. Superiority of the Child-Pugh classification to quantitative liver function tests for assessing prognosis of liver cirrhosis. Scand J Gastroenterol 1989;24:269-276.
39. Merkel C, Morabito A, Sacerdoti D, Bolognesi M, Angeli P, Gatta A. Updating prognosis of cirrhosis by Cox's regression model using Child-Pugh score and aminopyrine breath test as timedependent covariates. Ital J Gastroenterol Hepatol 1998;30: 276-282.
40. Chin SE, Shepherd RW, Thomas BJ, Cleghorn GJ, Patrick MK, Wilcox JA, Ong TH, Lynch SV, Strong R. Nutritional support in children with end-stage liver disease: a randomized crossover trial of a branched-chain amino acid supplement. Am J Clin Nutr 1992;56:158-163.